Buzzing Stocks: Pfizer, Rail Vikas Nigam, United Spirits, Bata, IndiGo & others in focus today


Results on May 19: NTPC, Power Grid Corporation of India, Punjab National Bank, JSW Steel, Zomato, Abbott India, Alkem Laboratories, Bandhan Bank, Cochin Shipyard, Crompton Greaves Consumer Electricals, Dilip Buildcon, Delhivery, Elgi Equipments, EPL, GATI, Glenmark Pharmaceuticals, Godrej Industries, IRB Infrastructure Developers, JK Lakshmi Cement, Minda Corporation, Muthoot Finance, Narayana Hrudayalaya, NLC India, Sun TV Network, VA Tech Wabag, and Welspun Enterprises will be in focus ahead of quarterly earnings on May 19. Results on May 19: NTPC, Power Grid Corporation of India, Punjab National Bank, JSW Steel, Zomato, Abbott India, Alkem Laboratories, Bandhan Bank, Cochin Shipyard, Crompton Greaves Consumer Electricals, Dilip Buildcon, Delhivery, Elgi Equipments, EPL, GATI, Glenmark Pharmaceuticals, Godrej Industries, IRB Infrastructure Developers, JK Lakshmi Cement, Minda Corporation, Muthoot Finance, Narayana Hrudayalaya, NLC India, Sun TV Network, VA Tech Wabag, and Welspun Enterprises will be in focus ahead of quarterly earnings on May 19.

Results on May 20: Divis Laboratories, Andhra Petrochemicals, Arihant Capital Markets, Atul Auto, Balaji Amines, Bharat Electronics, Godawari Power & Ispat, Multi Commodity Exchange of India, Nilkamal, Swan Energy, VRL Logistics, and Zuari Agro Chemicals will be in focus ahead of quarterly earnings on May 20. Results on May 20: Divis Laboratories, Andhra Petrochemicals, Arihant Capital Markets, Atul Auto, Balaji Amines, Bharat Electronics, Godawari Power & Ispat, Multi Commodity Exchange of India, Nilkamal, Swan Energy, VRL Logistics, and Zuari Agro Chemicals will be in focus ahead of quarterly earnings on May 20.

Wipro: The technology services and consulting company announced a five-year business partnership with ServiceNow to drive business transformation, overcome business challenges, and deliver greater value. The agreement is expected to help accelerate Wipro’s goal of building a $1 billion business with ServiceNow by the end of 2026. Wipro: The technology services and consulting company announced a five-year business partnership with ServiceNow to drive business transformation, overcome business challenges, and deliver greater value. The agreement is expected to help accelerate Wipro’s goal of building a $1 billion business with ServiceNow by the end of 2026.

Nexus Select Trust: The leading real estate investment trust is going to make a debut on the bourses on May 19. The issue price has been fixed at Rs 100 per unit. Nexus Select Trust: The leading real estate investment trust is going to make a debut on the bourses on May 19. The issue price has been fixed at Rs 100 per unit.

InterGlobe Aviation: The low-cost carrier IndiGo operator has recorded profit at Rs 919.2 crore for quarter ended March FY23, against loss of Rs 1,681.8 crore in same period last year, driven by healthy operating numbers and topline growth. Revenue from operations grew by 76.5% to Rs 14,160.6 crore compared to same period last year. EBITDAR for the quarter increased by more than 17-fold to Rs 2,966.5 crore compared to year-ago period. Passenger numbers in Q4FY23 increased by 60.5% YoY to 23.4 million. InterGlobe Aviation: The low-cost carrier IndiGo operator has recorded profit at Rs 919.2 crore for quarter ended March FY23, against loss of Rs 1,681.8 crore in same period last year, driven by healthy operating numbers and topline growth. Revenue from operations grew by 76.5% to Rs 14,160.6 crore compared to same period last year. EBITDAR for the quarter increased by more than 17-fold to Rs 2,966.5 crore compared to year-ago period. Passenger numbers in Q4FY23 increased by 60.5% YoY to 23.4 million.

Pfizer: The company has decided to initiate a voluntary recall of 3 products - Magnex 1gm, 2gm; Magnex Forte 1.5gm, 3gm; Zosyn 4.5gm; and Magnamycin 250mg, 1gm, 2gm injections - manufactured by Astral SteriTech. These products are marketed/distributed by Pfizer. Astral SteriTech informed Pfizer that it has observed an out-of-specification during a routine environmental monitoring of its manufacturing block. Astral manufactures three products for Pfizer, namely, Magnex, Magnamycin and Zosyn. Pfizer: The company has decided to initiate a voluntary recall of 3 products – Magnex 1gm, 2gm; Magnex Forte 1.5gm, 3gm; Zosyn 4.5gm; and Magnamycin 250mg, 1gm, 2gm injections – manufactured by Astral SteriTech. These products are marketed/distributed by Pfizer. Astral SteriTech informed Pfizer that it has observed an out-of-specification during a routine environmental monitoring of its manufacturing block. Astral manufactures three products for Pfizer, namely, Magnex, Magnamycin and Zosyn.

Bata India: The footwear company has reported a 4.4% year-on-year growth in standalone profit at Rs 65.5 crore in March FY23 quarter, impacted by weak operating margin performance. Revenue from operations grew by 17% to Rs 778.6 crore compared to same period last year. Bata India: The footwear company has reported a 4.4% year-on-year growth in standalone profit at Rs 65.5 crore in March FY23 quarter, impacted by weak operating margin performance. Revenue from operations grew by 17% to Rs 778.6 crore compared to same period last year.

United Spirits: The beverage alcohol company has recorded a 7.4% year-on-year growth in profit at Rs 204 crore for quarter ended March FY23 despite weak operating margin performance. Revenue fell 0.3% to Rs 2,494 crore compared to year-ago period. United Spirits: The beverage alcohol company has recorded a 7.4% year-on-year growth in profit at Rs 204 crore for quarter ended March FY23 despite weak operating margin performance. Revenue fell 0.3% to Rs 2,494 crore compared to year-ago period.

Rail Vikas Nigam: The railway company has formed one joint venture - Indore MMLP - with National Highways Logistics Management, and Madhya Pradesh Industrial Development Corporation. The joint venture will develop Multi Modal Logistics Parks across PAN India under Bharatmala Pariyojana. Rail Vikas Nigam: The railway company has formed one joint venture – Indore MMLP – with National Highways Logistics Management, and Madhya Pradesh Industrial Development Corporation. The joint venture will develop Multi Modal Logistics Parks across PAN India under Bharatmala Pariyojana.

BLS International Services: Promoter Diwakar Aggarwal has sold 1.12 crore equity shares or 2.72% stake in visa consultancy services provider via open market transactions at an average price of Rs 175.24 per share, amounting to Rs 196.3 crore. Diwakar Aggarwal among promoters held 8.49% stake or 3.48 crore shares in the company as of March 2023. BLS International Services: Promoter Diwakar Aggarwal has sold 1.12 crore equity shares or 2.72% stake in visa consultancy services provider via open market transactions at an average price of Rs 175.24 per share, amounting to Rs 196.3 crore. Diwakar Aggarwal among promoters held 8.49% stake or 3.48 crore shares in the company as of March 2023.

PNB Housing Finance Q4 profit jumps 65% YoY to Rs 279.3 crore, net interest income rises 27% to Rs 628 crore PNB Housing Finance: The housing finance company has reported a 64.7% year-on-year growth in profit at Rs 279.3 crore for March FY23 quarter on lower impairment on financial instruments & write-offs. Net interest income grew by 26.88% to Rs 627.7 crore compared to same quarter last year. PNB Housing Finance: The housing finance company has reported a 64.7% year-on-year growth in profit at Rs 279.3 crore for March FY23 quarter on lower impairment on financial instruments & write-offs. Net interest income grew by 26.88% to Rs 627.7 crore compared to same quarter last year.

Gland Pharma: The pharma company has registered a 72% year-on-year decline in profit at Rs 78.7 crore for quarter ended March FY23, dented by weak operating numbers and lower topline. Revenue from operations fell 29% YoY to Rs 785 crore in Q4FY23 with lower growth across markets. Production line shut down in Q4FY23 in Pashamylaram Penems facility due to line upgradation, and reduced business from domestic B2C division during the year as compared to previous year also impacted topline. Gland Pharma: The pharma company has registered a 72% year-on-year decline in profit at Rs 78.7 crore for quarter ended March FY23, dented by weak operating numbers and lower topline. Revenue from operations fell 29% YoY to Rs 785 crore in Q4FY23 with lower growth across markets. Production line shut down in Q4FY23 in Pashamylaram Penems facility due to line upgradation, and reduced business from domestic B2C division during the year as compared to previous year also impacted topline.

Tata Elxsi: The design led technology services provider has recorded a 26% year-on-year growth in profit at Rs 201.5 crore for March FY23 quarter despite lower operating margin, aided by lower tax cost and higher topline. Revenue from operations in Q4FY23 grew by 23% to Rs 838 crore compared to corresponding period previous fiscal. Tata Elxsi: The design led technology services provider has recorded a 26% year-on-year growth in profit at Rs 201.5 crore for March FY23 quarter despite lower operating margin, aided by lower tax cost and higher topline. Revenue from operations in Q4FY23 grew by 23% to Rs 838 crore compared to corresponding period previous fiscal.

Transport Corporation of India: The supply chain and logistics solutions provider has registered a 4.6% year-on-year decline in consolidated profit at Rs 81.5 crore in quarter ended March FY23, impacted by lower operating numbers. Revenue for the quarter at Rs 979.3 crore increased by 9% over year-ago period. The board has reappointed D P Agarwal as Chairman & Managing Director, and Vineet Agarwal as Managing Director for further five years each. Transport Corporation of India: The supply chain and logistics solutions provider has registered a 4.6% year-on-year decline in consolidated profit at Rs 81.5 crore in quarter ended March FY23, impacted by lower operating numbers. Revenue for the quarter at Rs 979.3 crore increased by 9% over year-ago period. The board has reappointed D P Agarwal as Chairman & Managing Director, and Vineet Agarwal as Managing Director for further five years each.

PI Industries: The chemical company has reported a 37% on-year growth in consolidated profit at Rs 280.6 crore for January-March FY23 quarter with better topline and operating performance. Revenue during the quarter increased by 12% to Rs 1,565.6 crore compared to same period last year. PI Industries: The chemical company has reported a 37% on-year growth in consolidated profit at Rs 280.6 crore for January-March FY23 quarter with better topline and operating performance. Revenue during the quarter increased by 12% to Rs 1,565.6 crore compared to same period last year.

Container Corporation of India: The transport company's consolidated profit grew by 7.8% year-on-year to Rs 279.1 crore for quarter ended March FY23, with better operating margin numbers. Consolidated revenue for the quarter at Rs 2,184.3 crore increased by 6.2% over corresponding period previous fiscal. Container Corporation of India: The transport company’s consolidated profit grew by 7.8% year-on-year to Rs 279.1 crore for quarter ended March FY23, with better operating margin numbers. Consolidated revenue for the quarter at Rs 2,184.3 crore increased by 6.2% over corresponding period previous fiscal.

G R Infraprojects: The construction engineering company has recorded a massive 40.9% year-on-year growth in consolidated profit at Rs 390 crore for March FY23 quarter despite muted topline, aided by strong operating numbers. Revenue for the quarter increased by 2.7% to Rs 2,461 crore compared to year-ago period. G R Infraprojects: The construction engineering company has recorded a massive 40.9% year-on-year growth in consolidated profit at Rs 390 crore for March FY23 quarter despite muted topline, aided by strong operating numbers. Revenue for the quarter increased by 2.7% to Rs 2,461 crore compared to year-ago period.

Sumitomo Chemical: The chemical company has registered a 3.4% year-on-year decline in consolidated profit at Rs 72.1 crore in Q4FY23, impacted by dismal operating performance. Revenue from operations fell by 1.9% to Rs 65.1 crore compared to same period last year. The board has appointed Chetan Shah as Managing Director of the company, and Sushil Marfatia as Executive Director for three years with effect from September 1 this year. Suresh Ramachandran has also been appointed as Whole-time Director of the company with effect from June 1, 2023. Sumitomo Chemical: The chemical company has registered a 3.4% year-on-year decline in consolidated profit at Rs 72.1 crore in Q4FY23, impacted by dismal operating performance. Revenue from operations fell by 1.9% to Rs 65.1 crore compared to same period last year. The board has appointed Chetan Shah as Managing Director of the company, and Sushil Marfatia as Executive Director for three years with effect from September 1 this year. Suresh Ramachandran has also been appointed as Whole-time Director of the company with effect from June 1, 2023.

Ujjivan Financial Services: The company has recorded a massive 95.4% growth in Q4FY23 consolidated profit at Rs 231.7 crore compared to corresponding period last fiscal. Consolidated revenue from operations grew by 45% to Rs 1,231.3 crore compared to year-ago period. Ujjivan Financial Services: The company has recorded a massive 95.4% growth in Q4FY23 consolidated profit at Rs 231.7 crore compared to corresponding period last fiscal. Consolidated revenue from operations grew by 45% to Rs 1,231.3 crore compared to year-ago period.

Uno Minda: The automotive components supplier has registered a 27% year-on-year growth in consolidated profit at Rs 183 crore for quarter ended March FY23, with revenue from operations growing 20% to Rs 2,889 crore and EBITDA rising 16% to Rs 319 crore compared to year-ago period. The board has approved raising up to Rs 1,500 crore via issue of securities in one or more tranches. Uno Minda: The automotive components supplier has registered a 27% year-on-year growth in consolidated profit at Rs 183 crore for quarter ended March FY23, with revenue from operations growing 20% to Rs 2,889 crore and EBITDA rising 16% to Rs 319 crore compared to year-ago period. The board has approved raising up to Rs 1,500 crore via issue of securities in one or more tranches.

RITES: The engineering services company has reported a 2.4% year-on-year fall in consolidated profit at Rs 139 crore for March FY23 quarter as revenue from operations for the quarter dropped 10.3% to Rs 686.8 crore compared to year-ago period. RITES: The engineering services company has reported a 2.4% year-on-year fall in consolidated profit at Rs 139 crore for March FY23 quarter as revenue from operations for the quarter dropped 10.3% to Rs 686.8 crore compared to year-ago period.

Laisser un commentaire